CNPEX
Price
$71.63
Change
-$0.40 (-0.56%)
Updated
Oct 7 closing price
Net Assets
164.4B
LSGGX
Price
$25.60
Change
-$0.18 (-0.70%)
Updated
Oct 7 closing price
Net Assets
143.46M
Interact to see
Advertisement

CNPEX vs LSGGX

Header iconCNPEX vs LSGGX Comparison
Open Charts CNPEX vs LSGGXBanner chart's image
American Funds New Perspective 529E
Price$71.63
Change-$0.40 (-0.56%)
VolumeN/A
Net Assets164.4B
Loomis Sayles Global Growth Y
Price$25.60
Change-$0.18 (-0.70%)
VolumeN/A
Net Assets143.46M
CNPEX vs LSGGX Comparison Chart in %
View a ticker or compare two or three
VS
CNPEX vs. LSGGX commentary
Oct 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNPEX is a Hold and LSGGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CNPEX has more cash in the bank: 164B vs. LSGGX (143M). CNPEX pays higher dividends than LSGGX: CNPEX (0.26) vs LSGGX (0.00). CNPEX was incepted earlier than LSGGX: CNPEX (24 years) vs LSGGX (10 years). LSGGX (1.13) is less costly to investors than CNPEX (1.00). CNPEX is a more actively managed with annual turnover of: 24.00 vs. LSGGX (6.00). CNPEX has a lower initial minimum investment than LSGGX: CNPEX (250) vs LSGGX (100000). LSGGX annual gain was more profitable for investors over the last year : 27.56 vs. CNPEX (13.48). LSGGX return over 5 years is better than : 44.34 vs. CNPEX (35.19).
CNPEXLSGGXCNPEX / LSGGX
Total Expense Ratio1.000.95105%
Annual Report Gross Expense Ratio1.001.1388%
Fund Existence24 years10 years-
Gain YTD19.08623.17282%
Front LoadN/AN/A-
Min. Initial Investment2501000000%
Min. Initial Investment IRAN/AN/A-
Net Assets164B143M114,685%
Annual Yield % from dividends0.260.00-
Returns for 1 year13.4827.5649%
Returns for 3 years63.09101.2562%
Returns for 5 years35.1944.3479%
Returns for 10 years102.77N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MAPIX17.18N/A
N/A
Matthews Asia Dividend Investor
ITHSX57.86N/A
N/A
Hartford Capital Appreciation R4
SHPCX13.51N/A
N/A
Saratoga Health & Biotechnology C
IUESX30.91N/A
N/A
JPMorgan International Focus I
SCSIX43.50N/A
N/A
Sterling Capital SmCp Val R6